Testing effectiveness (Phase 2)Study completedNCT00861809
What this trial is testing
The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis
Who this might be right for
Gastroparesis
GlaxoSmithKline 11